HomeNewsWorldFord joins GE, 3M in speeding up ventilator, respirator production

Ford joins GE, 3M in speeding up ventilator, respirator production

By joining forces with General Electric's healthcare unit and 3M Co, Ford is taking heed of U.S. President Donald Trump's call for U.S. automakers to work across sectors in producing equipment needed for the pandemic.

March 25, 2020 / 09:01 IST
Story continues below Advertisement
Ford
Ford

Carmaker Ford Motor Co jumped into the emergency push by major U.S. manufacturers to produce thousands of ventilators and respirators needed to help combat the spread of the coronavirus under a partnership code-named "Project Apollo."

By joining forces with General Electric's healthcare unit and 3M Co, Ford is taking heed of U.S. President Donald Trump's call for U.S. automakers to work across sectors in producing equipment needed for the pandemic.

Story continues below Advertisement

The rapid outbreak, which has killed more than 16,500 people globally, has strained healthcare systems around the world and led to a shortage of ventilators needed to treat patients suffering from the flu-like illness, which can lead to breathing difficulties and pneumonia in severe cases.

"We've been in regular dialogue with federal, state and local officials to understand the areas of greatest needs," Ford Chief Executive Jim Hackett said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show